These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16353427)

  • 1. Growth hormone secretion after testosterone administration to men with visceral obesity.
    Mårin P; Rosmond R; Bengtsson BA; Gustafsson C; Holm G; Björntorp P
    Obes Res; 1994 May; 2(3):263-70. PubMed ID: 16353427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.
    Utz AL; Yamamoto A; Sluss P; Breu J; Miller KK
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4033-40. PubMed ID: 18647804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A; Kaufman JM; Giagulli VA
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men.
    Rosmond R; Björntorp P
    Int J Obes Relat Metab Disord; 1998 Dec; 22(12):1184-96. PubMed ID: 9877254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
    Gentili A; Mulligan T; Godschalk M; Clore J; Patrie J; Iranmanesh A; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD
    Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low concentrations of insulin-like growth factor-I in abdominal obesity.
    Mårin P; Kvist H; Lindstedt G; Sjöström L; Björntorp P
    Int J Obes Relat Metab Disord; 1993 Feb; 17(2):83-9. PubMed ID: 8384169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.
    Münzer T; Harman SM; Hees P; Shapiro E; Christmas C; Bellantoni MF; Stevens TE; O'Connor KG; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3604-10. PubMed ID: 11502785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships of spontaneous growth hormone axis activity, body fat, and serum lipids in healthy elderly women and men.
    O'Connor KG; Harman SM; Stevens TE; Jayme JJ; Bellantoni MF; Busby-Whitehead MJ; Christmas C; Münzer T; Tobin JD; Roy TA; Cottrell E; St Clair C; Pabst KM; Blackman MR
    Metabolism; 1999 Nov; 48(11):1424-31. PubMed ID: 10582552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients.
    Maccario M; Ramunni J; Oleandri SE; Procopio M; Grottoli S; Rossetto R; Savio P; Aimaretti G; Camanni F; Ghigo E
    Int J Obes Relat Metab Disord; 1999 Jun; 23(6):612-8. PubMed ID: 10411234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone supplementation in older men restrains insulin-like growth factor's dose-dependent feedback inhibition of pulsatile growth hormone secretion.
    Veldhuis JD; Keenan DM; Bailey JN; Adeniji A; Miles JM; Paulo R; Cosma M; Soares-Welch C
    J Clin Endocrinol Metab; 2009 Jan; 94(1):246-54. PubMed ID: 18984660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables.
    Tchernof A; Labrie F; Bélanger A; Prud'homme D; Bouchard C; Tremblay A; Nadeau A; Després JP
    Atherosclerosis; 1997 Sep; 133(2):235-44. PubMed ID: 9298684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
    Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
    Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes.
    Fryburg DA; Weltman A; Jahn LA; Weltman JY; Samojlik E; Hintz RL; Veldhuis JD
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3710-9. PubMed ID: 9360530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.
    Johannsson G; Mårin P; Lönn L; Ottosson M; Stenlöf K; Björntorp P; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1997 Mar; 82(3):727-34. PubMed ID: 9062473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion.
    Douyon L; Schteingart DE
    Endocrinol Metab Clin North Am; 2002 Mar; 31(1):173-89. PubMed ID: 12055988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.